Cargando…

Clinical usefulness of Mac-2 binding protein glycosylation isomer for diagnosing liver cirrhosis and significant fibrosis in patients with chronic liver disease: A retrospective single-center study

Accurate diagnosis of liver cirrhosis (LC) and significant fibrosis in patients with chronic liver disease (CLD) is important. The Mac-2 binding protein glycosylation isomer (M2BPGi) has emerged as a novel serum biomarker for liver fibrosis; however, insufficient clinical data of M2BPGi are availabl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Hyun Joon, Seo, Kwang Il, Lee, Sang Uk, Han, Byung Hoon, Yun, Byung Cheol, Park, Eun Taek, Lee, Jinwook, Hwang, Hyunyong, Yoon, Myunghee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542736/ https://www.ncbi.nlm.nih.gov/pubmed/36221351 http://dx.doi.org/10.1097/MD.0000000000030489

Ejemplares similares

Combined albumin-bilirubin grade and Mac-2 binding protein glycosylation isomer as a useful predictor in compensated liver cirrhosis
por: Nishikawa, Hiroki, et al.
Publicado: (2019)

The Serum Mac-2-binding Protein Glycosylation Isomer Dynamics in Acute Liver Injury
por: Seike, Takuya, et al.
Publicado: (2020)

Clinical Utility of Mac-2 Binding Protein Glycosylation Isomer in Chronic Liver Diseases
por: Tamaki, Nobuharu, et al.
Publicado: (2021)

Diagnostic Efficacy of Serum Mac-2 Binding Protein Glycosylation Isomer and Other Markers for Liver Fibrosis in Non-Alcoholic Fatty Liver Diseases
por: Jang, Se Young, et al.
Publicado: (2021)

Mac-2 Binding Protein Glycosylation Isomer: Emerging Non-Invasive Serum Marker for Liver Fibrosis
por: Cho, Sun Young, et al.
Publicado: (2018)

Application of Mac-2 binding protein glycosylation isomer as a non-invasive biomarker for probing liver disease
por: Tangvoraphonkchai, Kawin, et al.
Publicado: (2022)

Mac-2-binding protein glycosylation isomer is useful to predict muscle cramps in patients with chronic liver disease
por: Miwa, Takao, et al.
Publicado: (2022)

Comparison of Non-Invasive Clinical Algorithms for Liver Fibrosis in Patients With Chronic Hepatitis B to Reduce the Need for Liver Biopsy: Application of Enhanced Liver Fibrosis and Mac-2 Binding Protein Glycosylation Isomer
por: Hur, Mina, et al.
Publicado: (2022)

Usefulness of Enhanced Liver Fibrosis, Glycosylation Isomer of Mac-2 Binding Protein, Galectin-3, and Soluble Suppression of Tumorigenicity 2 for Assessing Liver Fibrosis in Chronic Liver Diseases
por: Moon, Hee-Won, et al.
Publicado: (2018)

Diagnostic performance of Mac‐2 binding protein glycosylation isomer (M2BPGi) in screening liver fibrosis in health checkups
por: Nah, Eun‐Hee, et al.
Publicado: (2020)

Mac-2 binding protein glycosylation isomer (M2BPGi) to evaluate liver fibrosis and cancer in HBV-infected patients in West Africa
por: Vincent, Jeanne Perpétue, et al.
Publicado: (2022)

Elevation of Mac‐2 binding protein glycosylation isomer after hepatectomy is associated with post‐hepatectomy liver failure, total Pringle time, and renal dysfunction
por: Imai, Daisuke, et al.
Publicado: (2019)

Biological variation and reference change values of serum Mac‐2–binding protein glycosylation isomer (M2BPGi)
por: Choi, Rihwa, et al.
Publicado: (2022)

Serum Mac-2 Binding Protein Glycosylation Isomer Concentrations Are Associated With Incidence of Type 2 Diabetes
por: Higashioka, Mayu, et al.
Publicado: (2023)

Careful neurologic examination and treatment for intracranial hemorrhage after liver transplantation in patients with alcoholic cirrhosis: case reports
por: Noh, Byeonggwan, et al.
Publicado: (2021)

Mac-2 binding protein glycosylation isomer is a potential biomarker to predict portal hypertension and bacterial infection in cirrhotic patients
por: Wu, Pei-Shan, et al.
Publicado: (2021)

Chemical pleurodesis for the management of refractory hepatic hydrothorax in patients with decompensated liver cirrhosis
por: Lee, Woo Jin, et al.
Publicado: (2011)

Is there any vindication for low dose nonselective β-blocker medication in patients with liver cirrhosis?
por: Kim, Tae Wan, et al.
Publicado: (2012)

Liver transplantation for azithromycin-induced severe liver injury
por: Park, Hyun Joon, et al.
Publicado: (2020)

Usefulness of serum Mac-2 binding protein glycosylation isomer in patients undergoing hepatectomy: A case controlled study
por: Hiyoshi, Masahide, et al.
Publicado: (2019)

Pre-sarcopenia and Mac-2 binding protein glycosylation isomer as predictors of recurrence and prognosis of early-stage hepatocellular carcinoma
por: Nakai, Masato, et al.
Publicado: (2022)

Risk factors associated with hypophosphatemia in chronic Hepatitis B patients treated with tenofovir disoproxil fumarate
por: Lee, Dohyeong, et al.
Publicado: (2019)

Serum cytokine profiles and Mac-2 binding protein glycosylation isomer (M2BPGi) level in patients with autoimmune hepatitis
por: Migita, Kiyoshi, et al.
Publicado: (2018)

Mac‐2 Binding Protein Glycosylation Isomer as a Hepatocellular Carcinoma Marker in Patients With Chronic Hepatitis B or C Infection
por: Jun, Tomi, et al.
Publicado: (2019)

Mac-2 binding protein glycosylation isomer, the FIB-4 index, and a combination of the two as predictors of non-alcoholic steatohepatitis
por: Kiyoaki, Ito, et al.
Publicado: (2022)

Serum Mac-2 Binding Protein Glycosylation Isomer to Predict the Severity of Hepatic Fibrosis in Patients with Hepatitis C Virus Infection
por: Liu, Chen-Hua, et al.
Publicado: (2022)

Metronidazole-induced encephalopathy in a patient with liver cirrhosis
por: Cheong, Hyeong Cheol, et al.
Publicado: (2011)

Regression of esophageal varices during entecavir treatment in patients with hepatitis-B-virus-related liver cirrhosis
por: Jwa, Hye Young, et al.
Publicado: (2016)

Barriers to treatment of failed or interferon ineligible patients in the era of DAA: single center study
por: Seo, Kwang Il, et al.
Publicado: (2017)

Dobutamine stress echocardiography for evaluating cirrhotic cardiomyopathy in liver cirrhosis
por: Kim, Moon Young, et al.
Publicado: (2010)

Liver fibrosis assessments using FibroScan, virtual-touch tissue quantification, the FIB-4 index, and mac-2 binding protein glycosylation isomer levels compared with pathological findings of liver resection specimens in patients with hepatitis C infection
por: Ueda, Naoyuki, et al.
Publicado: (2020)

Regression of esophageal varices and splenomegaly in two patients with hepatitis-C-related liver cirrhosis after interferon and ribavirin combination therapy
por: Lee, Soon Jae, et al.
Publicado: (2016)

Serum Mac-2 binding protein glycosylation isomer level predicts hepatocellular carcinoma development in E-negative chronic hepatitis B patients
por: Mak, Lung-Yi, et al.
Publicado: (2019)

Measurements of Serum Mac-2-Binding Protein Glycosylation Isomer and Shear Wave Velocity in Health Checkups Are Useful in Screening for Non-Alcoholic Steatohepatitis
por: Tamai, Hideyuki, et al.
Publicado: (2021)

Etiology of liver cirrhosis in Brazil: chronic alcoholism and hepatitis viruses in liver cirrhosis diagnosed in the state of Espírito Santo
por: Gonçalves, Patricia Lofego, et al.
Publicado: (2013)

Clinical Features and Prognosis of Spontaneous Bacterial Peritonitis in Korean Patients with Liver Cirrhosis: A Multicenter Retrospective Study
por: Heo, Jeong, et al.
Publicado: (2009)

A Mac-2 Binding Protein Glycosylation Isomer-Based Risk Model Predicts Hepatocellular Carcinoma in HBV-Related Cirrhotic Patients on Antiviral Therapy
por: Chen, Chien-Hung, et al.
Publicado: (2022)

Bleeding complications in critically ill patients with liver cirrhosis
por: Cho, Jaeyoung, et al.
Publicado: (2016)

Littoral Cell Angioma (LCA) Associated with Liver Cirrhosis
por: Kim, Hi-Gu, et al.
Publicado: (2005)

Liver fibrosis is associated with risk for colorectal adenoma in patients with nonalcoholic fatty liver disease
por: Kim, Min Cheol, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_u9caqgj3cd8a72na17q4pleqkf